JPH10231292A5 - - Google Patents

Info

Publication number
JPH10231292A5
JPH10231292A5 JP1997278908A JP27890897A JPH10231292A5 JP H10231292 A5 JPH10231292 A5 JP H10231292A5 JP 1997278908 A JP1997278908 A JP 1997278908A JP 27890897 A JP27890897 A JP 27890897A JP H10231292 A5 JPH10231292 A5 JP H10231292A5
Authority
JP
Japan
Prior art keywords
phenoxy
piperidinyl
hydroxyphenyl
hydroxynaphthalene
ethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1997278908A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10231292A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH10231292A publication Critical patent/JPH10231292A/ja
Publication of JPH10231292A5 publication Critical patent/JPH10231292A5/ja
Withdrawn legal-status Critical Current

Links

JP9278908A 1996-10-10 1997-10-13 ２−アリール−３−アミノアリールオキシナフチル化合物、中間体、組成物及び方法 Withdrawn JPH10231292A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2844196P 1996-10-10 1996-10-10
US60/028441 1996-10-10

Publications (2)

Publication Number Publication Date
JPH10231292A JPH10231292A (ja) 1998-09-02
JPH10231292A5 true JPH10231292A5 (2) 2005-06-16

Family

ID=21843469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9278908A Withdrawn JPH10231292A (ja) 1996-10-10 1997-10-13 ２−アリール−３−アミノアリールオキシナフチル化合物、中間体、組成物及び方法

Country Status (8)

Country Link
EP (1) EP0835868B1 (2)
JP (1) JPH10231292A (2)
AT (1) ATE204868T1 (2)
CA (1) CA2217810A1 (2)
DE (1) DE69706386T2 (2)
DK (1) DK0835868T3 (2)
ES (1) ES2161417T3 (2)
PT (1) PT835868E (2)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0826679T1 (en) * 1996-08-29 2002-04-30 Eli Lilly And Company Naphthyl compounds and compositions
ID19392A (id) 1996-08-29 1998-07-09 Lilly Co Eli Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan
CA2287244A1 (en) * 1997-04-25 1998-11-05 Henry Uhlman Bryant Indene compounds having activity as serms
AU2092200A (en) * 1999-01-18 2000-08-01 Novo Nordisk A/S Use of estrogens and delta-gonadien-21-ol-3,20-diones
CN1294999C (zh) * 1999-08-03 2007-01-17 法马西雅公司 投放液体的容器
WO2001026651A2 (en) * 1999-10-14 2001-04-19 Endorecherche, Inc. Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance
EP1411922A1 (en) * 2001-07-31 2004-04-28 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
ATE433322T1 (de) * 2002-07-22 2009-06-15 Lilly Co Eli Selektive östrogenrezeptor modulatoren, die eine phenylsulfonyl-gruppe enthalten
CN100348192C (zh) * 2003-02-25 2007-11-14 伊莱利利公司 晶状的非溶剂化1－(4－(2－哌啶基乙氧基)苯氧基)－2－(4－甲磺酰基苯基)－6－羟基萘盐酸化物
EP1709021B1 (en) * 2004-01-22 2010-08-04 Eli Lilly And Company Selective estrogen receptor modulators for the treatment of vasomotor symptoms
CN1910167B (zh) * 2004-01-22 2011-08-10 伊莱利利公司 用于治疗血管舒缩症状的选择性雌激素受体调节剂
CA2571309A1 (en) 2004-06-22 2006-01-05 Smithkline Beecham Corporation Chemical compounds
FR2913017A1 (fr) * 2007-02-23 2008-08-29 Cerep Sa Derives de piperidine et piperazine comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire
CN114133336B (zh) * 2020-09-03 2024-04-02 沈阳药科大学 4-甲氧基萘取代的苯胺类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
US5811421A (en) * 1995-07-31 1998-09-22 Eli Lilly And Company Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods

Similar Documents

Publication Publication Date Title
JPH10231292A5 (2)
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
CN1125396A (zh) 阿司咪唑和假麻黄碱的缓释薄膜包衣片
CA2253453A1 (en) Alkylaminobenzothiazole and -benzoxazole derivatives
US4159335A (en) Substituted anilino-2-thiazolines
TW467913B (en) Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt and its preparation
EP0022118A1 (fr) Nouveaux dérivés de sulfonyl-aniline, leur procédé de préparation et leur application en thérapeutique
US6514529B2 (en) Oxazolidinone tablet formulation
US4379155A (en) 3,5-Disubstituted-1H-1,2,4-triazole derivatives
EP1265608B1 (en) Oxazolidinone tablet formulation
CA2576067A1 (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US20080234323A1 (en) Amorphous and Three Crystalline Forms of Rimonabant Hydrochloride
WO2023107980A1 (en) Solid state forms of an fgfr inhibitor
CA1316458C (en) Pharmaceutical composition for piperidinoalkanol derivatives
CA2077122A1 (en) Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same
CA2455858A1 (en) Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient
AU2001243243A1 (en) Oxazolidinone tablet formulation
CA1100511A (en) 3,5-disubstituted-1h-1,2,4-triazole derivatives
US3789125A (en) Pharmaceutical compositions containing halo-substituted 2-amino-benzylamine-amides
RU2001124835A (ru) Новые производные морфолина, способ их получения и содержащие их фармацевтические композиции
HUP0104514A2 (en) The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence
JPH02233677A (ja) 新規な１―〔３―（２―ヒドロキシ―３―アルキルアミノプロポキシ）―２―チエニル〕―３―フェニル―１―プロパノン類及びその製造方法
CY1499A (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist
US3993778A (en) Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use